Initial treatment for patients with chronic myeloid leukemia

M Baccarani1

  • 1Department of Hematology and Oncology 'L. and A. Seràgnoli', University of Bologna, S. Orsola-Malpighi Hospital , Bologna, Italy.

Insights

First-line chronic myeloid leukemia treatment uses tyrosine kinase inhibitors (TKIs). Newer TKIs like nilotinib and dasatinib offer improved outcomes over imatinib, potentially allowing treatment discontinuation.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Chronic myeloid leukemia (CML) treatment has evolved significantly.
  • Tyrosine kinase inhibitors (TKIs) are the cornerstone of CML management.
  • Current first-line therapies include imatinib, nilotinib, and dasatinib.

Purpose of the Study:

  • To review the current landscape of CML treatment.
  • To compare the efficacy and potential benefits of available TKIs.
  • To discuss the role of TKIs in treatment discontinuation and future therapeutic developments.

Main Methods:

  • Literature review of current CML treatment guidelines and clinical trials.
  • Comparative analysis of imatinib, nilotinib, and dasatinib efficacy.
  • Discussion of emerging TKIs and allogeneic stem cell transplantation.

Main Results:

  • Nilotinib and dasatinib demonstrate higher potency than imatinib.
  • These potent TKIs may reduce CML progression risk and enable treatment-free remission.
  • Hydroxyurea is no longer a primary treatment option for CML.

Conclusions:

  • First-line TKI therapy is standard for chronic phase CML.
  • Nilotinib and dasatinib represent advancements over imatinib, improving patient outcomes.
  • Allogeneic stem cell transplantation remains crucial for advanced CML or TKI resistance.

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.1K
Initiation of Translation02:33

Initiation of Translation

No description available
8.2K
Transcription Initiation01:47

Transcription Initiation

Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
21.2K
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
5.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.0K
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
12.3K